Effect of Dual Angiotensin Converting Enzyme/ Neutral Endopeptidase Inhibition, Angiotensin Converting Enzyme Inhibition, or AT1 Antagonism on Coronary Microvasculature in Spontaneously Hypertensive Rats

American Journal of Hypertension

Volumn 16, Issue 11 I, 2003, Pages 931-937

  Pu, Qian ^a   Larouche, Isabelle ^a   Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

ACE inhibitor; AT1 antagonist; Coronary microcirculation; Hypertension; Neutral endopeptidase

Indexed keywords

ACTIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENKEPHALINASE INHIBITOR; FOSINOPRIL; IRBESARTAN; OMAPATRILAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTERIOLE; ARTICLE; CAPILLARY; CELL DENSITY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; ENZYME INHIBITION; ESSENTIAL HYPERTENSION; HEART MUSCLE; HEART MUSCLE CAPILLARY; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; LOW DRUG DOSE; MALE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE;

EID: 0142231535     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(03)01029-X     Document Type: Article

References (35)

1. Brush JE, Cannon RO, Schenke WH, Bonow RO, Leon MB, Maron BJ, Epstein SE: Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988;319:1302-1307.
2. Anversa P, Li P, Sonnenblick EH, Olivetti G: Effect of aging on quantitative structural properties of coronary vasculature and microvasculature in rats. Am J Physiol 1994;267:H1062-H1073.
3. Breisch EA, White FC, Nimmo LE, Bloor CM: Cardiac vasculature and flow during pressure-overload hypertrophy. Am J Physiol 1986; 251:H1031-H1037.
4. Green AS, Tonellato PJ, Zhang Z, Lombard JH, Cowley AW Jr: Effect of microvascular rarefaction on tissue oxygen delivery in hypertension. Am J Physiol 1992;262:H1486-H1493.
5. Rakusan K, Flanagan MF, Geva T, Southern J, Van Praagh R: Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure overload hypertrophy. Circulation 1992;86:38-46.
6. Struyker-Boudier HAJ: Arteriolar and capillary remodeling in hypertension. Drugs 1999;58:43-47.
7. Rakusan K, Cicutti N, Maurin A, Guez D, Schiavi P: The effect of treatment with low dose ACE inhibitor and/or diuretic on coronary microvasculature in stroke-prone spontaneously hypertensive rats. Microvasc Res 2000;59:243-254.
8. Hansen-Smith FM, Morris LW, Green AS, Lombard JH: Rapid microvessel rarefaction with elevated salt intake and reduced renal mass hypertension in rats. Circ Res 1996;79:324-330.
9. Hernandez I, Cowley AW Jr, Lombard JH, Green AS: Salt intake and Ang II alter microvessel density in the cremaster muscle of normal rats. Am J Physiol 1992;263:H664-H667.
10. Noon JP, Walker BR, Webb DJ, Shore AC, Holton DW, Edward HV: Impaired microvascular dilation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest 1997;99:1873-1879.
11. A receptor antagonism. Hypertension 1999;34:795-801.
12. Le Noble FA, Hekking JW, Van Straaten HW, Slaaf DW, Struyker Boudier HA: Ang II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur J Pharmacol 1991;195:305-306.
13. Kobayashi N, Yanaka H, Tojo A, Kobayashi K, Matsuoka H: Effects of amlodipine on nitric oxide synthase mRNA expression and coronary microcirculation in prolonged nitric oxide blockade-induced hypertensive rats. J Cardiovasc Pharmacol 1999;34:173-181.
14. Munzenmaier DH, Greene AS: Opposing actions of Ang II on microvascular growth and arterial blood pressure. Hypertension 1996;27:760-765.
15. Sabri A, Samuel JL, Marotte F, Poitevin P, Rappaport L, Levy BI: Microvasculature in Ang II-dependent cardiac hypertrophy in the rat. Hypertension 1998;32:371-375.
16. Gohlke P, Kuwer I, Schnell A, Amann K, Mall G, Unger T, Gohlke P: Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats. Hypertension 1997;29:478-482.
17. Schwartzkopff B, Brehm M, Mundhenke M, Strauer BE: Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease. Hypertension 2000;36:220-225.
18. Wang DH, Prewitt RL: Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats. Hypertension 1990; 15:68-77.
19. Xie Z, Gao M, Togashi H, Saito H, Koyama T: Improvement in the capillarity of left ventricular wall of stroke-prone spontaneously hypertensive rats following Ang II receptor blockade. Clin Exp Hypertens 1999;21:441-452.
20. Itoh H, Pratt RE, Ohno M, Dzau VJ: Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells. Hypertension 1992;19:758-761.
21. Pedram A, Razandi M, Levin ER: Natriuretic peptides suppress vascular endothelial cell growth factor signaling to angiogenesis. Endocrinology 2001;142:1578-1586.
22. Burnett JC: Vasopeptidase inhibition. Curr Opin Nephrol Hypertens 2000;9:465-468.
23. Intengan HD, Schiffrin EL: Vasopeptidase inhibition has potent effects on blood pressure and resistance arteries in stroke-prone spontaneously hypertensive rats. Hypertension 2000;35:1221-1225.
24. Pu Q, Schiffrin EL: Effect of ACE/NEP inhibition on cardiac and vascular collagen in stroke-prone spontaneously hypertensive rats. Am J Hypertens 2001;14:1067-1072.
25. Price RJ, Owens GK, Skalak TC: Immunohistochemical identification of arteriolar development using markers of smooth muscle differentiation: evidence that capillary arterialization proceeds from terminal arterioles. Circ Res 1994;75:520-527.
26. Tomanek RJ, Palmer PJ, Peiffer GL, Schreiber KL, Eastham CL, Marcus ML: Morphometry of canine coronary arteries, arterioles, and capillaries during hypertension and left ventricular hypertrophy. Circ Res 1986;58:38-46.
27. Cao L, Gardner DG: Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension 1995;25:227-234.
28. Tamura N, Ogawa Y, Chusho H, Nakamura K, Nakao K, Suda M, Kasahara M, Hashimoto R, Katsuura G, Mukoyama M, Itoh H, Saito Y, Tanaka I, Otani H, Katsuki M: Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci U S A 2000; 97:4239-4244.
29. Itoh H, Nakao K: Antagonism between the vascular renin-angiotensin and natriuretic peptide systems in vascular remodelling. Blood Press Suppl 1994;5:49-53.
30. Dumoulin MJ, Adam A, Blais C Jr, Lamontagne D: Metabolism of bradykinin by the rat coronary vascular bed. Cardiovasc Res 1998; 38:229-236.
31. Costa MD, Bosc LV, Majowicz MP, Vidal NA, Balaszczuk AM, Arranz CT: Atrial natriuretic peptide modifies arterial blood pressure through nitric oxide pathway in rats. Hypertension 2000;35: 1119-1123.
32. Ogihara T, Rakugi H, Masuo K, Yu H, Nagano M, Mikami H: Antihypertensive effects of the neutral endopeptidase inhibitor SCH 42495 in essential hypertension. Am J Hypertens 1994;11:943-947.
33. Grantham JA, Schirger JA, Wennberg PW, Sandberg S, Heublein DM, Subkowski T, Burnett JC Jr: Modulation of functionally active endothelin-converting enzyme by chronic neutral endopeptidase inhibition in experimental atherosclerosis. Circulation 2000;101: 1976-1981.
34. Fournie-Zaluski MC, Gonzalez W, Turcaud S, Pham I, Roques BP, Michel JB: Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension. Proc Natl Acad Sci USA 1994;91:4072-4076.
35. Intengan HD, Thibault G, Li JS, Schiffrin EL: Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation 1999;100:2267-2275.